These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 28685356

  • 1. Is Pancreatic Head Cancer with Portal Venous Involvement Really Borderline Resectable? Appraisal of an Upfront Surgery Series.
    Ohgi K, Yamamoto Y, Sugiura T, Okamura Y, Ito T, Ashida R, Aramaki T, Uesaka K.
    Ann Surg Oncol; 2017 Sep; 24(9):2752-2761. PubMed ID: 28685356
    [Abstract] [Full Text] [Related]

  • 2. Reassessment of the clinical significance of portal-superior mesenteric vein invasion in borderline resectable pancreatic cancer.
    Hoshimoto S, Hishinuma S, Shirakawa H, Tomikawa M, Ozawa I, Wakamatsu S, Hoshi S, Hoshi N, Hirabayashi K, Ogata Y.
    Eur J Surg Oncol; 2017 Jun; 43(6):1068-1075. PubMed ID: 28427822
    [Abstract] [Full Text] [Related]

  • 3. National Comprehensive Cancer Network Resectability Status for Pancreatic Carcinoma Predicts Overall Survival.
    Murakami Y, Satoi S, Sho M, Motoi F, Matsumoto I, Kawai M, Honda G, Uemura K, Yanagimoto H, Shinzeki M, Kurata M, Kinoshita S, Yamaue H, Unno M.
    World J Surg; 2015 Sep; 39(9):2306-14. PubMed ID: 26013206
    [Abstract] [Full Text] [Related]

  • 4. Pancreaticoduodenectomy with portal vein/superior mesenteric vein resection for patients with pancreatic cancer with venous invasion.
    Wang WL, Ye S, Yan S, Shen Y, Zhang M, Wu J, Zheng SS.
    Hepatobiliary Pancreat Dis Int; 2015 Aug; 14(4):429-35. PubMed ID: 26256089
    [Abstract] [Full Text] [Related]

  • 5. Impact of Portal Vein Involvement from Pancreatic Cancer on Metastatic Pattern After Surgical Resection.
    Mierke F, Hempel S, Distler M, Aust DE, Saeger HD, Weitz J, Welsch T.
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):730-736. PubMed ID: 27554501
    [Abstract] [Full Text] [Related]

  • 6. Adverse tumor biology associated with mesenterico-portal vein resection influences survival in patients with pancreatic ductal adenocarcinoma.
    Wang F, Gill AJ, Neale M, Puttaswamy V, Gananadha S, Pavlakis N, Clarke S, Hugh TJ, Samra JS.
    Ann Surg Oncol; 2014 Jun; 21(6):1937-47. PubMed ID: 24558067
    [Abstract] [Full Text] [Related]

  • 7. Reconsideration about the aggressive surgery for resectable pancreatic cancer: a focus on real pathological portosplenomesenteric venous invasion.
    Okabayashi T, Shima Y, Iwata J, Morita S, Sumiyoshi T, Kozuki A, Saisaka Y, Tokumaru T, Iiyama T, Noda Y, Hata Y, Matsumoto M.
    Langenbecks Arch Surg; 2015 May; 400(4):487-94. PubMed ID: 25940756
    [Abstract] [Full Text] [Related]

  • 8. Preoperative defining system for pancreatic head cancer considering surgical resection.
    Yang SJ, Hwang HK, Kang CM, Lee WJ.
    World J Gastroenterol; 2016 Jul 14; 22(26):6076-82. PubMed ID: 27468199
    [Abstract] [Full Text] [Related]

  • 9. Long-term outcome of portomesenteric vein invasion and prognostic factors in pancreas head adenocarcinoma.
    Jeong J, Choi DW, Choi SH, Heo JS, Jang KT.
    ANZ J Surg; 2015 Apr 14; 85(4):264-9. PubMed ID: 24641800
    [Abstract] [Full Text] [Related]

  • 10. Inferior Infracolic 'Superior Mesenteric Artery First' Approach with a No-Touch Isolation Surgical Technique in Patients with a Borderline Resectable Cancer of the Pancreatic Head.
    Zhu J, Han D, Li X, Pan F, Ma J, Kou J, Fan H, Lang R, He Q.
    Ann Surg Oncol; 2016 Dec 14; 23(Suppl 5):976-980. PubMed ID: 27600620
    [Abstract] [Full Text] [Related]

  • 11. The impact of extent of pancreatic and venous resection on survival for patients with pancreatic cancer.
    Serenari M, Ercolani G, Cucchetti A, Zanello M, Prosperi E, Fallani G, Masetti M, Lombardi R, Cescon M, Jovine E.
    Hepatobiliary Pancreat Dis Int; 2019 Aug 14; 18(4):389-394. PubMed ID: 31230959
    [Abstract] [Full Text] [Related]

  • 12. Prognostic role of the length of tumour-vein contact at the portal-superior mesenteric vein in patients having surgery for pancreatic cancer.
    Imamura T, Yamamoto Y, Sugiura T, Okamura Y, Ito T, Ashida R, Ohgi K, Todaka A, Fukutomi A, Aramaki T, Uesaka K.
    Br J Surg; 2019 Nov 14; 106(12):1649-1656. PubMed ID: 31626342
    [Abstract] [Full Text] [Related]

  • 13. Feasibility of resecting the portal vein only when necessary during pancreatoduodenectomy for pancreatic cancer.
    Kishi Y, Nara S, Esaki M, Hiraoka N, Shimada K.
    BJS Open; 2019 Jun 14; 3(3):327-335. PubMed ID: 31183449
    [Abstract] [Full Text] [Related]

  • 14. Biological and conditional factors should be included when defining criteria for resectability for patients with pancreatic cancer.
    Kato Y, Yamada S, Tashiro M, Sonohara F, Takami H, Hayashi M, Kanda M, Kobayashi D, Tanaka C, Nakayama G, Koike M, Fujiwara M, Kodera Y.
    HPB (Oxford); 2019 Sep 14; 21(9):1211-1218. PubMed ID: 30773450
    [Abstract] [Full Text] [Related]

  • 15. Pancreatic adenocarcinoma with histologically proven portal vein infiltration: what is the outcome?
    Martin D, Petermann D, Fontanella S, Pu Y, Halkic N, Demartines N, Schäfer M.
    Eur J Gastroenterol Hepatol; 2018 Dec 14; 30(12):1507-1513. PubMed ID: 30222630
    [Abstract] [Full Text] [Related]

  • 16. Consensus in determining the resectability of locally progressed pancreatic ductal adenocarcinoma - results of the Conko-007 multicenter trial.
    Wittel UA, Lubgan D, Ghadimi M, Belyaev O, Uhl W, Bechstein WO, Grützmann R, Hohenberger WM, Schmid A, Jacobasch L, Croner RS, Reinacher-Schick A, Hopt UT, Pirkl A, Oettle H, Fietkau R, Golcher H.
    BMC Cancer; 2019 Oct 22; 19(1):979. PubMed ID: 31640628
    [Abstract] [Full Text] [Related]

  • 17. Portal or superior mesenteric vein resection in pancreatoduodenectomy for pancreatic head carcinoma.
    Murakami Y, Satoi S, Motoi F, Sho M, Kawai M, Matsumoto I, Honda G, Multicentre Study Group of Pancreatobiliary Surgery (MSG-PBS).
    Br J Surg; 2015 Jun 22; 102(7):837-46. PubMed ID: 25877050
    [Abstract] [Full Text] [Related]

  • 18. Radiographic tumor-vein interface as a predictor of intraoperative, pathologic, and oncologic outcomes in resectable and borderline resectable pancreatic cancer.
    Tran Cao HS, Balachandran A, Wang H, Nogueras-González GM, Bailey CE, Lee JE, Pisters PW, Evans DB, Varadhachary G, Crane CH, Aloia TA, Vauthey JN, Fleming JB, Katz MH.
    J Gastrointest Surg; 2014 Feb 22; 18(2):269-78; discussion 278. PubMed ID: 24129826
    [Abstract] [Full Text] [Related]

  • 19. Impact of portal vein infiltration and type of venous reconstruction in surgery for borderline resectable pancreatic cancer.
    Ravikumar R, Sabin C, Abu Hilal M, Al-Hilli A, Aroori S, Bond-Smith G, Bramhall S, Coldham C, Hammond J, Hutchins R, Imber C, Preziosi G, Saleh A, Silva M, Simpson J, Spoletini G, Stell D, Terrace J, White S, Wigmore S, Fusai G.
    Br J Surg; 2017 Oct 22; 104(11):1539-1548. PubMed ID: 28833055
    [Abstract] [Full Text] [Related]

  • 20. Pancreatic neck cancer has specific and oncologic characteristics regarding portal vein invasion and lymph node metastasis.
    Hirono S, Kawai M, Okada K, Miyazawa M, Shimizu A, Kitahata Y, Ueno M, Yamaue H.
    Surgery; 2016 Feb 22; 159(2):426-40. PubMed ID: 26253244
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.